Open access peer-reviewed Edited Volume

Dosage Forms

Katherine Dunnington

Celerion (United States)

Dr. Dunnington holds an interdisciplinary Ph.D. from the University of Missouri-Kansas City, she previously worked in MDS Pharma Services Lincoln, Nebraska, Principal Medical Writer PRA International Lenexa, KS, and Pharmacist Hen House Pharmacy Gladstone, Missouri. She is experienced in pharmacokinetics and clinical pharmacology with over 20 years of service in contract research.

Co-editor:

Christine Brandquist

Celerion (United States)

Dr. Brandquist has gained her Ph.D. at the College of Pharmacy, University of Nebraska Medical Center, Nevada, USA. In 2020, she has received the ACCP Excellence in Achievement Recognition and is currently a member of the American College of Clinical Pharmacology.

Covering

Formulation Pharmacokinetics Pharmacodynamics Extended-Release Immediate-Release Orally Disintegrating Tablet Lozenge Buccal Patch Nasal Spray Drops Irritancy Abuse Potential

Register your interest in contributing to this book

Collaborate with our community and contribute your knowledge.

About the book

This book will cover dosage form innovations in an interdisciplinary manner. Chapters may range from the development of new dosage forms or new dosage forms for previously marketed drugs to evaluation of their performance in dissolution experiments, animal models/humans, or a correlation of these. Many oral dosage forms are now extended release formulations in order to increase compliance by reducing the number of capsules/tablets that must be taken each day. Nasal and buccal delivery systems allow rapid absorption of acutely acting pharmaceuticals and allow for by-passing first-pass metabolism in gut and liver. Transdermal systems allow slow release of potent pharmaceuticals over longer periods of time, but adhesion and dermal irritancy are often challenges with these delivery methods. Topical application of drugs allow for action on the skin itself or for systemic delivery. Drug delivery to the eye, especially for drugs where systemic exposure should be avoided has been an ongoing challenge.

Publishing process

Book initiated and editor appointed

Date completed: August 27th 2021

Applications to edit the book are assessed and a suitable editor is selected, at which point the process begins.

Chapter proposals submitted and reviewed

Deadline Extended: Open for Submissions

Potential authors submit chapter proposals ready for review by the academic editor and our publishing review team.

Approved chapters written in full and submitted

Deadline for full chapters: November 23rd 2021

Once approved by the academic editor and publishing review team, chapters are written and submitted according to pre-agreed parameters

Full chapters peer reviewed

Review results due: February 11th 2022

Full chapter manuscripts are screened for plagiarism and undergo a Main Editor Peer Review. Results are sent to authors within 30 days of submission, with suggestions for rounds of revisions.

Book compiled, published and promoted

Expected publication date: April 12th 2022

All chapters are copy-checked and typesetted before being published. IntechOpen regularly submits its books to major databases for evaluation and coverage, including the Clarivate Analytics Book Citation Index in the Web of ScienceTM Core Collection. Other discipline-specific databases are also targeted, such as Web of Science's BIOSIS Previews.

About the editor

Katherine Dunnington

Celerion (United States)

Dr. Katherine 'Shelly' Dunnington resides and works in the Midwest United States in the state of Kansas. She is a pharmacokineticst with training in pharmaceutical science and cellular/molecular biology, and originally was a practicing pharmacist both in hospital and retail settings. She is currently a Senior Principal Scientist in the Data Management and Biometrics department at Celerion, a pharmaceutical contract research organization. With 21 years in contract research, Dr. Dunnington has many roles in her current position, including training/mentoring scientists; consulting on clinical study design and conduct; analysis, interpretation, and reporting of clinical PK/PD and cardiac safety data, and software validation. Dr. Dunnington holds both a bachelor's of science degree in pharmacy, as well as an interdisciplinary Ph.D. from the University of Missouri-Kansas City.

View profile

Book chapters authored 1

Books edited 0

Introducing your Author Service Manager

Ms. Jasna Bozic

As an Author Service Manager, my responsibilities include monitoring and facilitating all publishing activities for authors and editors. From chapter submission and review to approval and revision, copyediting and design, until final publication, I work closely with authors and editors to ensure a simple and easy publishing process. I maintain constant and effective communication with authors, editors and reviewers, which allows for a level of personal support that enables contributors to fully commit and concentrate on the chapters they are writing, editing, or reviewing. I assist authors in the preparation of their full chapter submissions and track important deadlines and ensure they are met. I help to coordinate internal processes such as linguistic review, and monitor the technical aspects of the process. As an ASM I am also involved in the acquisition of editors. Whether that be identifying an exceptional author and proposing an editorship collaboration, or contacting researchers who would like the opportunity to work with IntechOpen, I establish and help manage author and editor acquisition and contact.

Ask a question
creativecommons
alpsp
cope
stm
ithenticate
crossref
doi
oaspa

Book will be abstracted and indexed in

googlescholar
worldcat
base
az
openaire